Immunotherapy for High-Risk Neuroblastoma: Management of Side Effects and Complications

Despite more intensive therapy, high-risk neuroblastoma continues to be a challenging disease to treat. Postconsolidation immunotherapy has been studied for many years and has proven to be effective in clinical trials. Immunotherapy has become the standard of care for patients with high-risk disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Armideo, Erin, Callahan, Colleen, Madonia, Lara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995538/
https://www.ncbi.nlm.nih.gov/pubmed/29900016

Ejemplares similares

Ejemplares similares